Advisory Board July 9, 2024

By: Natalie Trebes, Vidal Seegobin, Susan McDonald, and Max Hakanson

The Supreme Court of the United States (SCOTUS) recently overturned the Chevron doctrine, which required courts to defer to federal agencies’ interpretation of ambiguous laws. Advisory Board’s Natalie Trebes, Vidal Seegobin, Susan McDonald, and Max Hakanson explain how this could impact healthcare and highlight what they’ll be watching in the post-Chevron era.

Bold predictions for healthcare in 2024

SCOTUS’ Chevron decision

In a 6-3 decision, SCOTUS overturned the Chevron doctrine on June 28, repealing a 40-year-old legal precedent that required courts to defer to regulatory agencies to interpret ambiguous laws.

Since Chevron v. Natural Resources Defense Council was decided in 1984, it has become one of the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Regulations
States have the power to influence health care
Vaccine misinformation: a lasting side effect from COVID
COVID's origins reviewed: Lab leak or natural spillover?
FTC: OpenAI-Microsoft Pact Could Bring ‘Competition Implications’
'Generational problem': Youth still struggling in pandemic's shadow

Share This Article